Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value: $22.67B (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 47,269,424 | $8.032B | 35.4% | $37.84 | — | COM | 812578102 |
| INCY | Incyte Corporation | 31,999,081 | $3.327B | 14.7% | $73.07 | +31.9% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 11,777,285 | $2.219B | 9.8% | $117.58 | — | SPONSORED ADR | 07725L102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 41,904,586 | $2.031B | 9.0% | $18.86 | +154.6% | COM | 004225108 |
| — | Alexion Pharmaceuticals, Inc. | 8,760,794 | $983M | 4.3% | $162.46 | — | COM | 015351109 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $936M | 4.1% | $81.02 | +22.7% | COM | 09061G101 |
| KOD | Kodiak Sciences Inc. | 11,574,538 | $626M | 2.8% | $15.71 | +259.1% | COM | 50015M109 |
| ASND | Ascendis Pharma A/S | 3,390,270 | $501M | 2.2% | $44.21 | — | SPONSORED ADR | 04351P101 |
| — | Invitae Corporation | 11,850,962 | $359M | 1.6% | $20.14 | — | COM | 46185L103 |
| — | MyoKardia, Inc. | 3,164,234 | $306M | 1.3% | $72.13 | — | COM | 62857M105 |
| — | Amarin Corporation plc | 34,496,685 | $239M | 1.1% | $8.93 | — | SPONSORED ADR | 023111206 |
| ARGX | argenx SE | 1,019,557 | $230M | 1.0% | $59.75 | — | SPONSORED ADR | 04016X101 |
| — | IGM Biosciences, Inc. | 3,144,223 | $230M | 1.0% | $17.75 | — | COM | 449585108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,499,212 | $170M | 0.7% | $104.81 | -6.2% | COM | 558868105 |
| — | Mirati Therapeutics, Inc. | 1,409,784 | $161M | 0.7% | $22.85 | — | COM | 60468T105 |
| EXAS | Exact Sciences Corporation | 1,846,139 | $161M | 0.7% | $87.91 | -9.1% | COM | 30063P105 |
| NBIX | Neurocrine Biosciences, Inc. | 906,986 | $111M | 0.5% | $62.87 | +75.8% | COM | 64125C109 |
| — | Principia Biopharma Inc. | 1,580,873 | $94.52M | 0.4% | $33.55 | — | COM | 74257L108 |
| — | Forma Therapeutics Holdings, Inc. | 2,000,000 | $92.98M | 0.4% | $46.49 | — | SHS | 34633R104 |
| CERS | Cerus Corporation | 13,713,195 | $90.51M | 0.4% | $4.64 | +23.5% | COM | 157085101 |
| HRTX | Heron Therapeutics, Inc. | 6,018,104 | $88.53M | 0.4% | $17.78 | -7.6% | COM | 427746102 |
| INSM | Insmed Incorporated | 3,025,384 | $83.32M | 0.4% | $22.18 | +6.9% | COM PAR $.01 | 457669307 |
| AXSM | Axsome Therapeutics, Inc. | 1,009,757 | $83.08M | 0.4% | $23.39 | +229.1% | COM | 05464T104 |
| ADCT | ADC Therapeutics SA | 1,687,500 | $78.99M | 0.3% | $38.22 | 0.0% | SHS | H0036K147 |
| — | Atreca, Inc. | 3,532,760 | $75.18M | 0.3% | $18.84 | — | CL A COM | 04965G109 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,799,577 | $71.33M | 0.3% | $17.35 | — | COM CL A | G5269C101 |
| ADAPY | Adaptimmune Therapeutics plc | 6,675,181 | $66.82M | 0.3% | $5.98 | — | SPONSORED ADR | 00653A107 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 13,766,405 | $65.6M | 0.3% | $6.35 | -37.1% | COM | 09058V103 |
| — | DBV Technologies S.A. | 14,614,264 | $64.16M | 0.3% | $19.06 | — | SPONSORED ADR | 23306J101 |
| — | Zymeworks Inc. | 1,708,472 | $61.63M | 0.3% | $14.76 | — | COM | 98985W102 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,700,055 | $60.21M | 0.3% | $26.63 | -26.8% | COM | 76243J105 |
| — | Neoleukin Therapeutics, Inc. | 3,397,740 | $56.4M | 0.2% | $2.85 | — | COM | 64049K104 |
| — | ChemoCentryx, Inc. | 945,221 | $54.39M | 0.2% | $35.60 | — | COM | 16383L106 |
| — | Allakos Inc. | 735,469 | $52.85M | 0.2% | $60.26 | — | COM | 01671P100 |
| — | Neurocrine Biosciences, Inc. | 30,770,000 | $51.14M | 0.2% | $1.24 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| — | Aeglea BioTherapeutics, Inc. | 4,379,592 | $40.51M | 0.2% | $7.84 | — | COM | 00773J103 |
| — | Assembly Biosciences, Inc. | 1,541,618 | $35.95M | 0.2% | $17.50 | — | COM | 045396108 |
| KRYS | Krystal Biotech, Inc. | 817,631 | $33.87M | 0.1% | $22.57 | +113.1% | COM | 501147102 |
| PTGX | Protagonist Therapeutics, Inc. | 1,911,446 | $33.76M | 0.1% | $9.97 | +25.8% | COM | 74366E102 |
| — | Merus N.V. | 2,037,469 | $32.78M | 0.1% | $10.77 | — | COM | N5749R100 |
| APLS | Apellis Pharmaceuticals, Inc. | 896,551 | $29.28M | 0.1% | $28.57 | +12.4% | COM | 03753U106 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,701,929 | $27.66M | 0.1% | $9.21 | +73.8% | COM | 05156V102 |
| ALKS | Alkermes plc | 1,244,744 | $24.15M | 0.1% | $24.20 | -32.9% | SHS | G01767105 |
| — | GW Pharmaceuticals plc | 185,045 | $22.71M | 0.1% | $132.99 | — | ADS | 36197T103 |
| ALT | Altimmune, Inc. | 2,107,600 | $22.57M | 0.1% | $5.49 | 0.0% | COM | 02155H200 |
| ADPT | Adaptive Biotechnologies Corporation | 463,539 | $22.43M | 0.1% | $44.30 | -17.7% | COM | 00650F109 |
| — | Frequency Therapeutics, Inc. | 945,719 | $21.99M | 0.1% | $17.53 | — | COM | 35803L108 |
| — | Tricida, Inc. | 787,582 | $21.64M | 0.1% | $29.10 | — | COM | 89610F101 |
| NVAX | Novavax, Inc. | 241,376 | $20.12M | 0.1% | $38.25 | 0.0% | COM | 670002401 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $18.34M | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| — | bluebird bio, Inc. | 265,000 | $16.18M | 0.1% | $58.05 | — | COM | 09609G100 |
| VXRT | Vaxart, Inc. | 1,639,121 | $14.51M | 0.1% | $2.87 | 0.0% | COM | 92243A200 |
| XNCR | Xencor, Inc. | 428,120 | $13.87M | 0.1% | $11.07 | +177.0% | COM | 98401F105 |
| — | Immunomedics, Inc. | 330,000 | $11.7M | 0.1% | $14.81 | — | COM | 452907108 |
| ANAB | AnaptysBio, Inc. | 513,677 | $11.48M | 0.1% | $26.06 | -29.8% | COM | 032724106 |
| MIRM | Mirum Pharmaceuticals, Inc. | 583,333 | $11.35M | 0.1% | $14.04 | +19.0% | COM | 604749101 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $11.26M | 0.0% | $16.20 | — | COM | 00900T107 |
| — | Horizon Therapeutics Public Ltd Co | 200,000 | $11.12M | 0.0% | $29.62 | — | SHS | G46188101 |
| QURE | uniQure N.V. | 230,883 | $10.4M | 0.0% | $18.33 | +222.2% | SHS | N90064101 |
| XENE | Xenon Pharmaceuticals Inc. | 799,102 | $10.02M | 0.0% | $12.73 | 0.0% | COM | 98420N105 |
| UROV | Urovant Sciences Ltd. | 1,000,000 | $9.84M | 0.0% | $15.51 | — | SHS | G9381B108 |
| — | Albireo Pharma, Inc. | 369,047 | $9.776M | 0.0% | $20.86 | — | COM | 01345P106 |
| — | Karuna Therapeutics, Inc. | 81,976 | $9.137M | 0.0% | $91.25 | — | COM | 48576A100 |
| FLGT | Fulgent Genetics, Inc. | 569,444 | $9.111M | 0.0% | $11.30 | +35.6% | COM | 359664109 |
| SGMO | Sangamo Therapeutics, Inc. | 999,823 | $8.958M | 0.0% | $11.28 | -17.8% | COM | 800677106 |
| — | Reata Pharmaceuticals, Inc. | 55,983 | $8.734M | 0.0% | $188.33 | — | CL A | 75615P103 |
| — | IVERIC bio, Inc. | 1,635,501 | $8.341M | 0.0% | $3.89 | — | COM | 46583P102 |
| — | Idera Pharmaceuticals, Inc. | 4,608,786 | $8.25M | 0.0% | $1.32 | — | COM PAR | 45168K405 |
| — | HOOKIPA Pharma Inc. | 700,481 | $8.14M | 0.0% | $6.73 | — | COM | 43906K100 |
| AUTL | Autolus Therapeutics plc | 485,624 | $7.785M | 0.0% | $19.50 | — | SPON ADS | 05280R100 |
| — | Passage Bio, Inc. | 275,000 | $7.516M | 0.0% | $15.75 | — | COM | 702712100 |
| — | Syros Pharmaceuticals, Inc. | 690,167 | $7.357M | 0.0% | $13.72 | — | COM | 87184Q107 |
| CABA | Cabaletta Bio, Inc. | 636,363 | $7.089M | 0.0% | $11.85 | -35.4% | COM | 12674W109 |
| ALEC | Alector, Inc. | 280,000 | $6.843M | 0.0% | $25.49 | +8.3% | COM | 014442107 |
| — | Burning Rock Biotech Limited | 250,000 | $6.753M | 0.0% | $27.01 | — | SPONSORED ADS | 12233L107 |
| TARA | Protara Therapeutics, Inc. | 199,671 | $5.854M | 0.0% | $30.96 | 0.0% | COM STK | 74365U107 |
| LEGN | Legend Biotech Corporation | 135,000 | $5.746M | 0.0% | $42.56 | — | SPONSORED ADS | 52490G102 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 317,857 | $5.569M | 0.0% | $22.63 | -24.7% | COM | 22663K107 |
| — | CymaBay Therapeutics, Inc. | 1,522,792 | $5.315M | 0.0% | $3.49 | — | COM | 23257D103 |
| — | Chiasma, Inc. | 946,701 | $5.093M | 0.0% | $5.38 | — | COM | 16706W102 |
| IFRX | Inflarx N.V. | 1,058,555 | $4.859M | 0.0% | $2.91 | +123.1% | COM | N44821101 |
| — | Abeona Therapeutics Inc. | 1,590,686 | $4.637M | 0.0% | $5.53 | — | COM | 00289Y107 |
| — | Evofem Biosciences, Inc. | 1,425,000 | $4.033M | 0.0% | $4.22 | — | COM | 30048L104 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $4.007M | 0.0% | $6.73 | — | COM | 210373106 |
| OVID | Ovid Therapeutics Inc. | 458,253 | $3.377M | 0.0% | $4.48 | +4.4% | COM | 690469101 |
| — | Kezar Life Sciences, Inc. | 600,000 | $3.108M | 0.0% | $5.18 | — | COM | 49372L100 |
| VKTX | Viking Therapeutics, Inc. | 425,000 | $3.064M | 0.0% | $11.90 | -44.2% | COM | 92686J106 |
| — | Gamida Cell Ltd. | 666,666 | $3.047M | 0.0% | $4.57 | — | SHS | M47364100 |
| — | Dicerna Pharmaceuticals, Inc. | 119,335 | $3.031M | 0.0% | $20.57 | — | COM | 253031108 |
| RCUS | Arcus Biosciences, Inc. | 121,534 | $3.007M | 0.0% | $15.69 | +72.0% | COM | 03969F109 |
| — | Global Blood Therapeutics, Inc. | 47,000 | $2.967M | 0.0% | $51.09 | — | COM | 37890U108 |
| — | Aravive, Inc. | 244,055 | $2.841M | 0.0% | $5.03 | — | COM | 03890D108 |
| NTLA | Intellia Therapeutics, Inc. | 128,538 | $2.702M | 0.0% | $26.35 | -35.5% | COM | 45826J105 |
| GLPG | Galapagos NV | 13,072 | $2.579M | 0.0% | $51.50 | — | SPON ADR | 36315X101 |
| — | Acceleron Pharma Inc. | 27,000 | $2.572M | 0.0% | $89.85 | — | COM | 00434H108 |
| DNLI | Denali Therapeutics Inc. | 104,900 | $2.536M | 0.0% | $20.86 | +12.7% | COM | 24823R105 |
| — | NGM Biopharmaceuticals, Inc. | 124,400 | $2.456M | 0.0% | $14.64 | — | COM | 62921N105 |
| — | Orchard Therapeutics plc | 405,702 | $2.434M | 0.0% | $14.53 | — | ADS | 68570P101 |
| — | Applied Therapeutics, Inc. | 65,934 | $2.384M | 0.0% | $32.68 | — | COM | 03828A101 |
| — | ARYA Sciences Acquisition Corp. | 150,000 | $2.361M | 0.0% | $10.18 | — | SHS CL A | G3165V109 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 500,000 | $2.31M | 0.0% | $2.70 | +66.3% | COM | 14888U101 |
| — | Molecular Templates, Inc. | 158,217 | $2.182M | 0.0% | $7.45 | — | COM | 608550109 |
| — | Oyster Point Pharma, Inc. | 71,428 | $2.063M | 0.0% | $28.88 | — | COM | 69242L106 |
| — | Leap Therapeutics, Inc. | 978,454 | $2.045M | 0.0% | $1.17 | — | COM | 52187K101 |
| — | Bellicum Pharmaceuticals, Inc. | 249,123 | $1.851M | 0.0% | $4.71 | — | COM | 079481404 |
| — | Matinas BioPharma Holdings, Inc. | 2,096,375 | $1.62M | 0.0% | $0.90 | — | COM | 576810105 |
| — | Galmed Pharmaceuticals Ltd. | 215,594 | $1.031M | 0.0% | $11.90 | — | SHS | M47238106 |
| — | Affimed N.V. | 200,000 | $923K | 0.0% | $6.30 | — | COM | N01045108 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $525K | 0.0% | $1.54 | -38.0% | COM | 45665G303 |
| — | Marker Therapeutics, Inc. | 240,505 | $498K | 0.0% | $5.55 | — | COM | 57055L107 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $442K | 0.0% | $14.46 | — | COM | 00548A106 |
| GNFTY | Genfit SA | 28,396 | $156K | 0.0% | $14.24 | — | ADS | 372279109 |
| — | Sunesis Pharmaceuticals, Inc. | 556,665 | $147K | 0.0% | $4.37 | — | COM | 867328700 |
| REPL | Replimune Group, Inc. | 5,141 | $128K | 0.0% | $17.69 | 0.0% | COM | 76029N106 |